Meanwhile, AKR1B1 inhibition could block the mTOR pathway activation by activating 5′ adenosine monophosphate-activated protein kinase (AMPK) as it inhibits the phosphorylation of mTOR, Raptor, eIF4E, S6K, and 4E-BP1, thus inhibiting tumor growth. Here, RPTOR is linked to neoplasm.